Chinese Firms Up Their Game In Novel Flu Antiviral Development

 
• By Dexter Jie Yan
  
flu tablet
domestic commercial rights to three novel flu antivirals changed hands in China in 2023 • Source: Shutterstock

More from China

More from Focus On Asia